Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.44
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review
February 02, 2024
The Dow led the major indexes higher. Big techs diverged on results.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bristol Myers Shares Rise On Fourth-Quarter Earnings Beat
February 02, 2024
Bristol Myers earnings came in above expectations, although Opdivo sales were slower than expected. BMY stock gained.
Via
Investor's Business Daily
Is the Worst Over for Pfizer?
February 01, 2024
Pfizer shares sank 43% last year.
Via
The Motley Fool
Peeling Back The Layers: Exploring Pfizer Through Analyst Insights
January 31, 2024
Via
Benzinga
Why NYSE:PFE is a Top Pick for Dividend Investors.
January 30, 2024
Balancing Dividends and Fundamentals: The Case of PFIZER INC (NYSE:PFE).
Via
Chartmill
Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off
February 02, 2024
Seven stocks set to soar: Foundries to pharma, finance's evolution, and digital transformation—unlock million-dollar opportunities.
Via
InvestorPlace
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a...
Via
Benzinga
Exposures
COVID-19
Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market
February 01, 2024
Pfizer is in Wall Street's doghouse, but don't despair. At its current price, value seekers ought to relish the opportunity to buy PFE stock.
Via
InvestorPlace
What's Going On With Pfizer Stock Today?
February 01, 2024
Pfizer stock update: Q4 earnings beat expectations with adjusted EPS of $0.10, while FY2023 shows a 72% YoY decline. Explore 2024 R&D plans and recent program discontinuations.
Via
Benzinga
Topics
Earnings
Exposures
Financial
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
January 31, 2024
Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up.
Via
InvestorPlace
Listen to Wall Street and Buy These 3 Stocks Now
January 31, 2024
With a Wall Street recommended stock, you have the comfort of expert analysis along with a possible market-moving influence.
Via
InvestorPlace
3 Standout Stocks That Crushed Q4 Earnings Estimates
January 31, 2024
These three stocks crushing Q4 earnings are on the rise after the companies behind them closed the year with a bang.
Via
InvestorPlace
Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts
January 31, 2024
The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
Eli Lilly to report strong Q4 earnings thanks to successful diabetes treatments, while rivals like Novo Nordisk and Pfizer are also vying for a share of the weight-loss market.
Via
Benzinga
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
Via
Benzinga
Exposures
COVID-19
Best Income Stocks 2024
January 31, 2024
The pros and cons of 7 companies in 4 different sectors.
Via
Talk Markets
Pfizer (PFE) Q4 2023 Earnings Call Transcript
January 30, 2024
PFE earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Pfizer Stock Was Jumping Today, but Then Gave Up Its Gains
January 30, 2024
The drugmaker's Q4 results were better than many expected, but still not good enough to spark a sustained rally.
Via
The Motley Fool
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
US Stocks Edge Lower; Pfizer Reports Surprise Profit
January 30, 2024
U.S. stocks traded slightly lower this morning on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 38,316.43 while the NASDAQ fell 0.12% to 15,608.59. The S&P 500 also fell,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer Q4 Results: $14.25B In Revenue And EPS Of $0.1, Exceeding Forecasts
January 30, 2024
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
Via
Talk Markets
Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall
January 30, 2024
The company also reiterated its guidance for the full year.
Via
Investor's Business Daily
Exposures
COVID-19
Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance
January 30, 2024
Pfizer's Q4 2023 financial report: adjusted EPS beats estimates at $0.10, FY2023 EPS down 72%, Q4 sales decline 41% to $14.25B. CEO's positive outlook and reaffirmed 2024 guidance.
Via
Benzinga
Exposures
COVID-19
US Stocks Hold Steady Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of 'Big Air Pocket' In Pivotal Trading Week
January 30, 2024
After a record run, U.S. stocks could pause for a breather ahead of the tech earnings deluge that is expected to hit the Street this week.
Via
Benzinga
Tuesday Talk: A Good Month - Two Days To Go
January 30, 2024
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the
Via
Talk Markets
Earnings Scheduled For January 30, 2024
January 30, 2024
Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.
Via
Benzinga
Investor Optimism Improves Slightly Ahead Of Big Earnings, Fed's Policy Decision
January 30, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the "Extreme Greed" zone on Monday.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Markets Stroll Higher Ahead Of Key Data; SMCI, FFIV, WHR Beat
January 29, 2024
One sign that we’re in a resilient bull market presently is that we’ve strolled into a potentially thorny period of economic and earnings data with market levels up more than a week straight, and we...
Via
Talk Markets
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.